The Food and Drug Administration is reportedly providing guidance and “positive feedback” for a proposed nalmefene product that will last…
Massachusetts is considering multiple proposals that, taken together, would make the landscape of overdose response increasingly hostile toward people who…
Less than two months after an investigation into deceptive marketing prompted Indivior Inc. to stop promoting its overdose antidote Opvee,…
Indivior PLC has discontinued marketing for Opvee, the opioid-overdose reversal product that the pharmaceutical company had claimed was more effective…
Indigenous people face persistent disparities in access to harm reduction services in the United States. In response, Native American health…
From New York City to rural Oklahoma and across the world, harm reduction vending machines are gaining popularity. They offer…
Indivior PLC, the pharmaceutical company that manufactures the opioid overdose antidote Opvee (nalmefene), has published new research showing that its…
The Trump administration has decided to destroy the AmeriCorps program, which puts millions of people, mostly volunteers, to work in…
Seven years ago, a deeply controversial paper claimed that states introducing laws to expand naloxone led to increases in opioid-related…
Since the Food and Drug Administration approved over-the-counter (OTC) naloxone in 2023, pharmacies nationwide have stocked their shelves with the…